Science News from ESC 2023

Circulation Editor-in-Chief Nancy Sweitzer, MD interview investigator Mikhail Kosiborod, MD about the results of STEP HFpEF, which found that weekly administration of 2.4 mg semaglutide resulted in more pronounced decreases in HF–related symptoms and physical constraints, along with a higher level of weight loss compared to the placebo over the course of 52 weeks.

Jose Joglar, MD interviews investigator David Conen, MD MPH about the results of the COP-AF trial which found that colchicine did not significantly reduce incidence of co-primary outcomes of clinically important AF or MINS in patients undergoing major noncardiac thoracic surgery.

Presenter: Xinli Li | The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Manesh Patel, MD interviews investigator Holger Thiele, MD about the results of ECLS-SHOCK, which found that adding extracorporeal life support (ECLS) did not improve 30-day all-cause mortality outcomes in patients presenting with acute myocardial infarction and cardiogenic shock compared to standard medical care.

Presenter: Masahiro Natsuaki | Saga University, Saga, Japan

Presenter: Linda Joosten| Julius Center for Health Sciences and Primary Care, Ulrecht, The Netherlands